首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   104670篇
  免费   8728篇
  国内免费   6127篇
耳鼻咽喉   1113篇
儿科学   1544篇
妇产科学   2304篇
基础医学   12408篇
口腔科学   1949篇
临床医学   14012篇
内科学   16580篇
皮肤病学   894篇
神经病学   5677篇
特种医学   3533篇
外国民族医学   42篇
外科学   11243篇
综合类   14796篇
现状与发展   23篇
一般理论   20篇
预防医学   6116篇
眼科学   2871篇
药学   10704篇
  56篇
中国医学   4838篇
肿瘤学   8802篇
  2024年   280篇
  2023年   1504篇
  2022年   3806篇
  2021年   4975篇
  2020年   3522篇
  2019年   3242篇
  2018年   3543篇
  2017年   2923篇
  2016年   2843篇
  2015年   4410篇
  2014年   5619篇
  2013年   5006篇
  2012年   7525篇
  2011年   8265篇
  2010年   4979篇
  2009年   3816篇
  2008年   5271篇
  2007年   5529篇
  2006年   5404篇
  2005年   5699篇
  2004年   3830篇
  2003年   3398篇
  2002年   3005篇
  2001年   2440篇
  2000年   2650篇
  1999年   2703篇
  1998年   1578篇
  1997年   1481篇
  1996年   1309篇
  1995年   1162篇
  1994年   982篇
  1993年   635篇
  1992年   998篇
  1991年   805篇
  1990年   684篇
  1989年   600篇
  1988年   593篇
  1987年   529篇
  1986年   420篇
  1985年   330篇
  1984年   208篇
  1983年   159篇
  1982年   85篇
  1981年   98篇
  1980年   83篇
  1979年   115篇
  1978年   54篇
  1977年   56篇
  1975年   44篇
  1974年   45篇
排序方式: 共有10000条查询结果,搜索用时 32 毫秒
21.
肖静  黄和平 《护理研究》2006,20(1):175-176
我科开展整体护理以来,将护理程序应用能力作为基础护理技能纳入临床护理教学计划中,提高了实习质量。现将具体做法介绍如下。  相似文献   
22.
用氯胺-T法125I标记眼镜蛇毒示踪液及抗眼镜蛇毒血清。小白鼠分二组,用125I-眼镜蛇毒、125I-抗眼镜蛇毒血清分别给小白鼠尾静脉注射,于注射后的不同时间测定血、颈部肌肉、肝、肺、肾、心等脏器放射性分布。结果发现:125I-眼镜蛇毒在肌肉及肝、肺等器官中于注射后2小时过高峰,在肾脏中浓度高,在脑未见放射性分布,抗眼镜蛇毒血清与眼镜蛇毒分布相似但在肌肉及肺脏有更高的分布。证明抗眼镜蛇毒血清能跟踪分布眼镜蛇毒。  相似文献   
23.
采用核桃仁泥外敷治疗138例(实验组)肌肉注射后皮下硬结,并与40例(对照组)采用新鲜土豆片外敷硬结法比较。结果表明:实验组患者治疗15天后Ⅰ度和Ⅱ度硬结治愈率分别为81.13%和42.25%,总有效率达92.03%,明显优于对照组(P<0.001)。  相似文献   
24.
25.
The cellular and regional distribution of glutathione (GSH) and GSH-related enzyme systems involved in cellular defense against reactive oxygen species and electrophilic xenobiotics in the nervous system has been extensively studied. However, little is known about the subcellular distribution of GSH systems in brain tissue and cultured neural cells. The present study investigates the distribution of mitochondrial and cytosolic GSH and GSH-related enzymes in cultured cerebellar astrocytes and granule cells, and compares them with levels in the adult rat cerebellum. Cytosolic GSH levels and cytosolic activities of glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione-S-transferase (GST) in astrocytes were 57, 153, 245, and 92% higher than those found in granule cells, respectively. In contrast, granule cells contained significantly higher mitochondrial GSH levels than astrocytes. Granule cells also demonstrated comparable mitochondria/cytosolic concentrations of GSH and GR, GPX and GST activities to those observed in the cerebellar tissue, whereas ratios in astrocytes were markedly lower. Although in vitro treatments with 100 μM ethacrynic acid depleted both cytosolic and mitochondrial GSH in cultured astrocytes and granule cells in a time-dependent fashion, cellular GSH in granule cells was more resistant to the GSH-depleting agent than astrocytes. These results suggest that although GSH and GSH-related enzymes are abundant in cytosolic compartments of astrocytes, mitochondrial pools are relatively small. Since brain mitochondria are sites of significant hydrogen peroxide generation, the mitochondrial localization of GSH and its associated enzymes in neural cells provide important defenses against toxic oxygen species in the nervous system. Differences in subcellular distribution of GSH systems in individual neural cell types may provide a basis for selective cellular and/or subcellular expression of neurotoxicity.  相似文献   
26.
27.
28.
In 1998, an epithermal neutron test beam was designed and constructed at the Tsing Hua Open-Pool Reactor (THOR) for the purpose of preliminary dosimetric experiments in boron neutron capture therapy (BNCT). A new epithermal neutron beam was designed at this facility, and is currently under construction, with clinical trials targeted in late 2004. Depth dose-rate distributions for the THOR BNCT test beam have been measured by means of activation foil and dual ion chamber techniques. Neutron and structure-induced gamma spectra measured at the test beam exit were configured into a source function for the Monte Carlo-based treatment planning code NCTPlan. Dose-rate scaling factors (DRSFs) were determined to normalize computationally derived dose-rate distributions with experimental measurements in corresponding mathematical and physical phantoms, and to thus enable accurate treatment planning using the NCTPlan code. A similar approach will be implemented in characterizing the new THOR epithermal beam in preparation for clinical studies. This paper reports the in-phantom calculated and experimental dosimetry comparisons and derived DRSFs obtained with the THOR test beam.  相似文献   
29.
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号